{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:16:45Z","timestamp":1791400605246,"version":"4.3.3"},"reference-count":30,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"crossref","award":["ABT-199\/GDC-"],"award-info":[{"award-number":["ABT-199\/GDC-"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2018,4,3]]},"DOI":"10.1080\/10428194.2017.1361024","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T06:59:33Z","timestamp":1502434773000},"page":"871-879","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma"],"prefix":"10.1080","volume":"59","author":[{"given":"Apurvasena","family":"Parikh","sequence":"first","affiliation":[{"name":"Clinical Pharmacology and Pharmacometrics, Abbvie Inc, North Chicago, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathej","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Pharmacometrics, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Freise","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Pharmacometrics, Abbvie Inc, North Chicago, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Verdugo","sequence":"additional","affiliation":[{"name":"Oncology Development, Abbvie Inc, North Chicago, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev M.","family":"Menon","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Pharmacometrics, Abbvie Inc, North Chicago, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mensing","sequence":"additional","affiliation":[{"name":"Pharmacometrics, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9261-1583","authenticated-orcid":false,"given":"Ahmed Hamed","family":"Salem","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Pharmacometrics, Abbvie Inc, North Chicago, IL, USA;"},{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"CIT0001","unstructured":"American Cancer Society [Internet]. Treating B-cell non-Hodgkin lymphoma; [cited 2017 Mar 20]. Available from: http:\/\/www.cancer.org\/cancer\/non-hodgkinlymphoma\/detailedguide\/non-hodgkin-lymphoma-treating-b-cell-lymphoma"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-016-2144-1"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1038\/nrc883"},{"key":"CIT0004","volume-title":"Venclexta (venetoclax) [US prescribing information]","year":"2016"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513257"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0313"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.4320"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.712"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood.V128.22.102.102","volume":"128","author":"Wei A","year":"2016","journal-title":"Blood"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.741"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.821"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13175"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.730"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.01.003"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.858"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-016-0485-9"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000522"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0453-9"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3144-1"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2373"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-016-9927-9"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.7865"},{"key":"CIT0024","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2014"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.7906"},{"key":"CIT0026","unstructured":"Center for Drug Evaluation and Research [Internet]. Clinical pharmacology and biopharmaceutics review for ibrutinib. Application Number 205552Orig1s000; [cited 2017 Mar 20]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/205552Orig1s000ClinPharmR.pdf"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2016-2045"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31820e17cb"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28281"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401471101"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2017.1361024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T22:00:22Z","timestamp":1602712822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2017.1361024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,7,21]]},"published-print":{"date-parts":[[2018,4,3]]}},"alternative-id":["10.1080\/10428194.2017.1361024"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2017.1361024","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-08-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}